v3.24.3
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Parent
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss, Net
Accumulated Deficit
Noncontrolling Interest
AOCI Attributable to Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2022     2,099,075,000          
Beginning balance at Dec. 31, 2022 $ 2,642,437 $ 2,565,326 $ 2,099 $ 8,427,998 $ (5,333) $ (5,859,438) $ 77,111  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares)     35,332,000          
Issuance of common stock from the exercise of stock options 166,829 166,829 $ 35 166,794        
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)     40,834,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 40 (40)        
Stock-based compensation 343,298 343,298   343,298        
Other comprehensive income (loss)   (1,872)     (1,872)      
Other, net 743           743  
Net income 120,462 116,434       116,434 4,028  
Ending balance (in shares) at Sep. 30, 2023     2,175,241,000          
Ending balance at Sep. 30, 2023 3,271,897 3,190,015 $ 2,174 8,938,050 (7,205) (5,743,004) 81,882  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Other comprehensive income (loss) (1,872)              
Beginning balance (in shares) at Jun. 30, 2023     2,149,980,000          
Beginning balance at Jun. 30, 2023 3,035,138 2,955,474 $ 2,149 8,773,043 (5,209) (5,814,509) 79,664  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares)     10,889,000          
Issuance of common stock from the exercise of stock options 50,556 50,556 $ 11 50,545        
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)     14,372,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 14 (14)        
Stock-based compensation 114,476 114,476   114,476        
Other comprehensive income (loss) (1,996)       (1,996)      
Other, net 284           284  
Net income 73,439 71,505       71,505 1,934  
Ending balance (in shares) at Sep. 30, 2023     2,175,241,000          
Ending balance at Sep. 30, 2023 3,271,897 3,190,015 $ 2,174 8,938,050 (7,205) (5,743,004) 81,882  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Other comprehensive income (loss) $ (1,996)              
Beginning balance (in shares) at Dec. 31, 2023 2,200,128,000   2,200,128,000          
Beginning balance at Dec. 31, 2023 $ 3,560,965 3,475,561 $ 2,200 9,122,173 801 (5,649,613) 85,404  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares) 44,188,000   44,188,000          
Issuance of common stock from the exercise of stock options $ 270,207 270,207 $ 45 270,162        
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)     27,273,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 27 (27)        
Stock-based compensation 410,668 410,668   410,668        
Other comprehensive income (loss) 4,138 4,124     4,124      
Net income $ 390,982 383,181       383,181 7,801  
Ending balance (in shares) at Sep. 30, 2024 2,269,809,000   2,269,809,000          
Ending balance at Sep. 30, 2024 $ 4,591,362 4,498,143 $ 2,270 9,757,380 4,925 (5,266,432) 93,219  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock Repurchased During Period, Shares     (1,780,000)          
Stock Repurchased During Period, Value (45,598) (45,598) $ (2) (45,596)        
Other comprehensive income (loss)               $ 14
Beginning balance (in shares) at Jun. 30, 2024     2,237,939,000          
Beginning balance at Jun. 30, 2024 4,137,806 4,050,524 $ 2,238 9,463,178 (4,935) (5,409,957) 87,282  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares)     23,312,000          
Issuance of common stock from the exercise of stock options 170,337 170,337 $ 24 170,313        
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)     9,183,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 9 (9)        
Stock-based compensation 142,796 142,796   142,796        
Other comprehensive income (loss) 9,981 9,860     9,860      
Net income $ 149,341 143,525       143,525 5,816  
Ending balance (in shares) at Sep. 30, 2024 2,269,809,000   2,269,809,000          
Ending balance at Sep. 30, 2024 $ 4,591,362 4,498,143 $ 2,270 9,757,380 $ 4,925 $ (5,266,432) $ 93,219  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock Repurchased During Period, Shares     (625,000)          
Stock Repurchased During Period, Value $ (18,899) $ (18,899) $ (1) $ (18,898)        
Other comprehensive income (loss)               $ 121